Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

Think of biotech and the bioeconomy as a broad methodology encompassing all those who use and borrow from biology to produce ...

Entero has signed a binding term sheet in which private biotech Journey is slated to acquire 99% of Entero’s equity, ...

Discover six exosome therapy companies developing these tiny extracellular vesicles to treat an array of diseases.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key clinical candidates for these companies: ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

Looking at longer-term growth for Legend. We recently announced a new research facility being built in Philadelphia, which is ...

Hera Biotech is developing a less invasive, more accurate diagnostic test for endometriosis, an often painful condition that ...

We take a look at 4 Pharma & Biotech companies whose share prices rallied in October on the back of positive announcements.

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...